We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
SEI Investments
SEIC
$12.4B
| $1.07M | ﹤0.01% |
12,623
-79,918
| -86% | -$7.1M |
|
702
Hayward Holdings
HAYW
$3.28B
| $1.07M | ﹤0.01% |
70,609
-62,023
| -47% | -$950K |
|
703
Zentalis Pharmaceuticals
ZNTL
$329M
| $1.06M | ﹤0.01% |
700,576
-157,006
| -18% | -$235K |
|
704
Graham Holdings Company
GHC
$5.23B
| $1.06M | ﹤0.01% |
898
-200
| -18% | -$207K |
|
|
PINE
705
Alpine Income Property Trust
PINE
$337M
| $1.05M | ﹤0.01% |
74,421
+39,079
| +111% | +$571K |
|
706
Penske Automotive Group
PAG
$14.5B
| $1.05M | ﹤0.01% |
6,033
-4,725
| -44% | -$842K |
|
|
BOW
707
Bowhead Specialty Holdings
BOW
$1.06B
| $1.05M | ﹤0.01% |
38,793
+5,402
| +16% | +$169K |
|
708
Skywest
SKYW
$4.51B
| $1.04M | ﹤0.01% |
10,288
-14,991
| -59% | -$1.67M |
|
709
Ginkgo Bioworks
DNA
$503M
| $1.03M | ﹤0.01% |
+70,867
| New | +$848K |
|
710
Anika Therapeutics
ANIK
$202M
| $1.03M | ﹤0.01% |
109,814
-9,524
| -8% | -$91K |
|
|
TERN
711
DELISTED
Terns Pharmaceuticals
TERN
| $1.03M | ﹤0.01% |
136,979
-65,591
| -32% | -$419K |
|
712
Fate Therapeutics
FATE
$270M
| $1.03M | ﹤0.01% |
814,639
-399,097
| -33% | -$430K |
|
713
Novavax
NVAX
$1.21B
| $1.02M | ﹤0.01% |
117,708
-10,436
| -8% | -$81.2K |
|
714
Signet Jewelers
SIG
$3.81B
| $1.02M | ﹤0.01% |
10,630
-36,951
| -78% | -$3.17M |
|
715
Core Molding Technologies
CMT
$207M
| $1.02M | ﹤0.01% |
49,455
-7,431
| -13% | -$138K |
|
716
Flexsteel Industries
FLXS
$317M
| $1.02M | ﹤0.01% |
21,900
-192
| -0.9% | -$7.96K |
|
717
Republic Bancorp
RBCAA
$1.97B
| $1.01M | ﹤0.01% |
13,983
-154
| -1% | -$11.4K |
|
718
Innospec
IOSP
$2.12B
| $1.01M | ﹤0.01% |
13,089
-8,967
| -41% | -$749K |
|
719
Dorian LPG
LPG
$1.9B
| $1.01M | ﹤0.01% |
33,883
-353
| -1% | -$10.6K |
|
720
Blackbaud
BLKB
$1.65B
| $1M | ﹤0.01% |
15,604
-69,988
| -82% | -$4.58M |
|
721
Rackspace Technology
RXT
$967M
| $993K | ﹤0.01% |
703,976
-555,302
| -44% | -$744K |
|
722
RE/MAX Holdings
RMAX
$206M
| $992K | ﹤0.01% |
105,249
-9,896
| -9% | -$87.4K |
|
|
SLDE
723
Slide Insurance Holdings
SLDE
$2.45B
| $992K | ﹤0.01% |
+62,814
| New | +$1.03M |
|
724
Unity Bancorp
UNTY
$593M
| $982K | ﹤0.01% |
20,088
+665
| +3% | +$33.8K |
|
725
SolarEdge
SEDG
$2.44B
| $977K | ﹤0.01% |
+26,413
| New | +$789K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.